Health Care & Life Sciences » Pharmaceuticals | Nicoccino Holding AB

Nicoccino Holding AB | Balance Sheet

Fiscal year is January-December. All values SEK Thousands.
2014
2015
2016
2017
Cash & Short Term Investments
13,966.00
36,285.00
24,321.00
17,531.00
Total Accounts Receivable
808.00
1,002.00
432.00
284.00
Inventories
5,366.00
5,670.00
-
-
Other Current Assets
44.00
1,914.00
175.00
79.00
Total Current Assets
20,184.00
44,871.00
24,928.00
17,894.00
Net Property, Plant & Equipment
253.00
231.00
457.00
391.00
Intangible Assets
110,004.00
108,986.00
960.00
311.00
Total Assets
130,441.00
154,088.00
26,345.00
18,596.00
Accounts Payable
837.00
924.00
345.00
87.00
Other Current Liabilities
1,491.00
4,623.00
1,968.00
796.00
Total Current Liabilities
2,328.00
5,547.00
2,313.00
883.00
Total Liabilities
2,328.00
5,547.00
2,313.00
883.00
Common Equity (Total)
128,113.00
148,541.00
24,032.00
17,713.00
Total Shareholders' Equity
128,113.00
148,541.00
24,032.00
17,713.00
Total Equity
128,113.00
148,541.00
24,032.00
17,713.00
Liabilities & Shareholders' Equity
130,441.00
154,088.00
26,345.00
18,596.00

About Nicoccino Holding AB

View Profile
Address
Lahällsvägen 48
Täby AB 183 30
Sweden
Employees -
Website http://www.nicoccino.se
Updated 09/14/2018
Nicoccino Holding AB engages in the development, administration, and marketing of alternative nicotine product free from tobacco. Its Nicotine Replacement Therapy, delivers a potent nicotine effect without the side effects of smoking. The company was founded by Fredrik Hübinette on September 11, 2013 and is headquartered in Taby, Sweden.